Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results
BRIIMultiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic soralimixin Strong Cash Position to Pursue New Discovery Opportunities and Partnership Strategy Conference Calls...
August 21, 2025Earnings
Read more →